BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chillappagari S, Garapati V, Mahavadi P, Naehrlich L, Schmeck BT, Schmitz ML, Guenther A. Defective BACH1/HO-1 regulatory circuits in cystic fibrosis bronchial epithelial cells. J Cyst Fibros 2021;20:140-8. [PMID: 32534959 DOI: 10.1016/j.jcf.2020.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Li A, Gao J, Liang J, Cao N, Zhou S, Tang X. Differences in the characteristics and pulmonary toxicity of nano- and micron-sized respirable coal dust. Respir Res 2022;23:197. [PMID: 35906696 DOI: 10.1186/s12931-022-02120-8] [Reference Citation Analysis]
2 NandyMazumdar M, Paranjapye A, Browne J, Yin S, Leir SH, Harris A. BACH1, the master regulator of oxidative stress, has a dual effect on CFTR expression. Biochem J 2021;478:3741-56. [PMID: 34605540 DOI: 10.1042/BCJ20210252] [Reference Citation Analysis]
3 Soares VEM, do Carmo TIT, Dos Anjos F, Wruck J, de Oliveira Maciel SFV, Bagatini MD, de Resende E Silva DT. Role of inflammation and oxidative stress in tissue damage associated with cystic fibrosis: CAPE as a future therapeutic strategy. Mol Cell Biochem 2021. [PMID: 34529223 DOI: 10.1007/s11010-021-04263-6] [Reference Citation Analysis]
4 Di Pietro C, Öz HH, Murray TS, Bruscia EM. Targeting the Heme Oxygenase 1/Carbon Monoxide Pathway to Resolve Lung Hyper-Inflammation and Restore a Regulated Immune Response in Cystic Fibrosis. Front Pharmacol 2020;11:1059. [PMID: 32760278 DOI: 10.3389/fphar.2020.01059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Ryter SW. Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders. Antioxidants 2022;11:555. [DOI: 10.3390/antiox11030555] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]